Dr. Williams is the Chief Scientific Officer and the Director of Early Phase Clinical Trials at the Avera Cancer Institute in Sioux Falls, South Dakota. Dr. Williams received his Pharm.D. from Creighton University and subsequently completed his PGY-1 residency in Pharmacy Practice at the University of North Carolina, and his PGY-2 Oncology Practice residency at the University of Texas/Audie Murphy VA.
Dr. Williams has faculty appointments at the University of Kansas School of Pharmacy, South Dakota State University School of Pharmacy and the University of South Dakota School Of Medicine. He is a fellow of the Hematology/Oncology Pharmacy Association and the past chair of Board of Pharmaceutical Specialties Oncology Specialty Council.
Dr. Williams has an excess of 100 peer reviewed abstracts and manuscripts and is currently the Principal Investigator of phase 1 clinical trials investigating the role of combination therapy in the treatment of early and advanced malignancies.